FIELD: chemistry.
SUBSTANCE: invention relates to compounds of general formula 
where R1 denotes CH3; R2 denotes halogen or CN; R3 denotes H or CH3; R4 denotes H or CH3; n equals 1; and pharmaceutically acceptable salts thereof. The invention also relates to a pharmaceutical composition and use of compounds of formula (I) in preparing a medicinal agent, having CX3CR1 receptor antagonist activity.
EFFECT: compounds can be used as CX3CR1 receptor antagonists.
13 cl, 1 tbl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW 5,7-DISUBSTITUTED [1,3]THIAZOLO-[4,5-d]PYRIMIDIN-2(3H)-ONE DERIVATIVES AND THEIR APPLICATION IN THERAPY | 2007 |
|
RU2441012C2 |
| NEW DERIVATIVES OF 5, 7-DISUBSTITUTED [1, 3] THIAZOLO[4, 5-D] PYRIMIDINE-2(3H)-ONE | 2006 |
|
RU2411245C9 |
| NEW DERIVATIVES OF 5-SUBSTITUTED 7-AMINO-[1, 3] THIAZOLO [4, 5-d]PYRIMIDINE | 2006 |
|
RU2419623C2 |
| PHOSPHATE AND PHOSPHONATE DERIVATIVES OF 7-AMINO-5-THIOTHIAZOLO[4,5-d]PYRIMIDINES AND THEIR USE FOR THE TREATMENT OF PATHOLOGICAL CONDITIONS ASSOCIATED WITH ELEVATED LEVELS OF CX3CR1 AND/OR CX3CL1 | 2019 |
|
RU2801664C2 |
| COMPOUNDS AND COMPOSITIONS USED FOR TREATMENT OF NTRK-RELATED DISORDERS | 2016 |
|
RU2744974C2 |
| METHOD OF STEREOSELECTIVE PREPARATION OF CHIRAL 2-[(HETERO)ARYLAKYLSULPHANYL]PYRIMIDINES AND PRODUCTS OBTAINED FROM THEM | 2019 |
|
RU2813355C2 |
| PIPERIDINE DERIVATIVES | 2011 |
|
RU2554353C2 |
| RMT5 INHIBITORS | 2019 |
|
RU2814198C2 |
| CYCLOALKANE DERIVATIVE | 2013 |
|
RU2635354C2 |
| PRODRUG OF THE AMINO ACID DERIVATIVE | 2017 |
|
RU2739318C2 |
